Evidence map›Paper›PMID 35517767›Full record

ArticleRSC advances2020

Glycolytic and lipid oxidative metabolic programs are essential for freshly-isolated regulatory T cells in mice with sepsis.

Xiaomei Zhu, WenQing Ji, Shubin Guo, Di Zhu, Yue Yang, Xin Liu

Open access · goldAbstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 4 countries.

Xiaomei ZhuBeijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation, Emergency Department, Chao-Yang Hospital, Capital Medical University Chaoyang District Beijing 100020 China shubinguo@126.com.ORCID https://orcid.org/0000-0003-4193-1955
WenQing JiBeijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation, Emergency Department, Chao-Yang Hospital, Capital Medical University Chaoyang District Beijing 100020 China shubinguo@126.com.
Shubin GuoBeijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation, Emergency Department, Chao-Yang Hospital, Capital Medical University Chaoyang District Beijing 100020 China shubinguo@126.com.
Di ZhuBeijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation, Emergency Department, Chao-Yang Hospital, Capital Medical University Chaoyang District Beijing 100020 China shubinguo@126.com.
Yue YangBeijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation, Emergency Department, Chao-Yang Hospital, Capital Medical University Chaoyang District Beijing 100020 China shubinguo@126.com.
Xin LiuBeijing Key Laboratory of Cardiopulmonary-Cerebral Resuscitation, Emergency Department, Chao-Yang Hospital, Capital Medical University Chaoyang District Beijing 100020 China shubinguo@126.com.
Capital University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immunometabolism determines the fate and function of regulatory T cells. The metabolic phenotype of regulatory T cells (Treg) is affected by various factors. The relationship between Treg metabolism and function of mice with sepsis is not clear. We used liquid chromatography and tandem mass spectrometry (LC-MS/MS) to analyze the metabolic profiles of freshly-isolated spleen Treg cells in mice with sepsis. It was found that in severe infection, activated Treg cells depend on glycolysis and fatty acid oxidation, and inhibition of metabolic pathways has a significant impact on the number and quality of Treg cells. Understanding the metabolic characteristics of Treg cells in the real environment in the body helps to grasp the function of Treg cells and even the overall immune status. Targeting the metabolic pathway of Treg may provide a new method for the treatment of sepsis.

Identifiers

PMID35517767
PMCPMC9054272
OpenAlexW3033012862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.